Shareholder alert: pomerantz law firm reminds shareholders with losses on their investment in acadia pharmaceuticals inc. of class action lawsuit and upcoming deadline - acad

New york, new york--(newsfile corp. - july 11, 2022) - pomerantz llp announces that a class action lawsuit has been filed against acadia pharmaceuticals inc. (nasdaq: acad) ("acadia" or the "company") and certain of its officers. the class action, filed in the united states district court for the southern district of california, and docketed under 21-cv-00762, is on behalf of a class consisting of all persons and entities other than defendants that purchased...
ACAD Ratings Summary
ACAD Quant Ranking